Metformin

CD59 molecule (CD59 blood group) ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32097995 Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement. 2020 Feb 4
2 32138474 Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement. 2020 Mar 31 4
3 29435189 Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease. 2018 Jan 12 1
4 30326091 Metformin use was linked to hospitalization for acidosis at 6 y only in patients with eGFR < 30 mL/min/1.73 m2. 2018 Oct 16 1
5 27330129 Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety! 2016 Jul 1
6 26338686 Metformin initiation and renal impairment: a cohort study in Denmark and the UK. 2015 Sep 2 3
7 26705203 Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study. 2015 Dec 1
8 24842984 Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. 2014 Aug 2
9 23755710 [How I treat ... with metformin a diabetic patient with moderate renal insufficiency]. 2013 Apr 1
10 24047401 AMP-activated protein kinase as a promoting factor, but complement and thrombin as limiting factors for acquisition of cytoprotection: implications for induction of accommodation. 2013 Nov 1
11 21435929 Trends in the quality of care for elderly people with type 2 diabetes: the need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys). 2011 Apr 1
12 20977579 Limitations of metformin use in patients with kidney disease: are they warranted? 2010 Dec 3
13 11118008 Mechanism by which metformin reduces glucose production in type 2 diabetes. 2000 Dec 1
14 8412779 The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. 1993 Sep 1
15 2272714 Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly). 1990 Aug 1